filter wheel lambda-10 Search Results


lambda 10 2 filter wheel  (Sutter Instrument Company)
95
Sutter Instrument Company lambda 10 2 filter wheel
Lambda 10 2 Filter Wheel, supplied by Sutter Instrument Company, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lambda 10 2 filter wheel/product/Sutter Instrument Company
Average 95 stars, based on 1 article reviews
lambda 10 2 filter wheel - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier
filter wheels  (Sutter Instrument Company)
95
Sutter Instrument Company filter wheels
Filter Wheels, supplied by Sutter Instrument Company, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/filter wheels/product/Sutter Instrument Company
Average 95 stars, based on 1 article reviews
filter wheels - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier
lambda 10 3  (Sutter Instrument Company)
93
Sutter Instrument Company lambda 10 3
(A–G) Null mutants lacking one or both type-I myosin. Cells express Sla2-GFP (A–D) or Abp1-GFP (E–G). (A) MSD plots for wild-type and myo5 Δ patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (B) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (C) Average time at the origin, from the appearance of a patch until it moved away or disappeared. (D) Phase II movement only. For each patch, data prior to movement were removed. (E) MSD plots for wild-type and mutant patches aligned at the start (left) or end (right) of their lifetimes. On the left, plots are truncated at the median lifetime or 16 s, whichever was less. (F) Percentage of patches that leave the origin, as in (B). (G) Average time at the origin, as in (C). (H–M) Mutants lacking Arp2/3-binding regions of one or both type-I myosins, termed myo3 Δ acidic and myo5 Δ acidic . The panels are similar to those above, with cells expressing Sla2-GFP (H–J) or Abp1-GFP (K–M). (H and K) MSD plots for wild-type or mutant patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (I and L) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (J and M) Average time at the origin, from the appearance of a patch until it moved away or disappeared. (N–S) Mutants lacking Arp2/3 binding regions of WASp/Las17 and type-I myosins. Cells express Sla2-GFP (N–P) or Abp1-GFP (Q–S). (N and Q) MSD plots for wild-type or mutant patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (O and P) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (R and S) Average time at the origin, from the appearance of a patch until it moved away or disappeared. Strain numbers and number of patches: (A–C) Wild-type, YJC4787–9; 94, 79, and 90. myo5 Δ, YJC4784–6; 103, 79, and 69. (D) Strains as in (A–C). Numbers of patches: wild-type – 88, 69, 85. myo5 Δ – 75, 40, 36. (E–G) Wild-type, YJC4815–7; 121, 110, and 130. myo3 Δ, YJC4409–11; 111, 115, and 105. myo5 Δ, YJC4813–4; 120 and 99. myo3 Δ myo5 Δ, YJC4770–2; 143, 141, and 126. (H–J) Wild-type, YJC5566–8; 71, 107, and 83. myo3 Δ acidic , YJC5563–5; 71, 75, and 101. myo5 Δ acidic , YJC5554–6; 86, 71, and 62. myo3 Δ acidic myo5 Δ acidic , YJC5557–9; 83, 65, and 83. (K–M) Wild-type, YJC4848 and 50; 116 and 87. myo3 Δ acidic , YJC4843–5; 119, 99, and 106. myo5 Δ acidic , YJC4840–2; 102, 111, and 99. myo3 Δ acidic myo5 Δ acidic , YJC4837–9; 96, 93, and 100. (N–P) Wild-type, YJC5566–8; 71, 107, and 83. las17 Δ acidic , YJC5551–3; 84, 64, and 69. las17 Δ acidic myo3 Δ acidic , YJC5560–2; 89, 71, and 68. las17 Δ acidic myo5 Δ acidic , YJC5548–50; 51, 66, and 57. las17 Δ acidic myo3 Δ acidic myo5 Δ acidic , YJC5545–7; 43, 53, and 54. (Q–S) las17 Δ acidic , YJC5208–10; 95, 76, and 89. las17 Δ acidic myo3 Δ acidic , YJC5438–40; 111, 104, and 109. las17 Δ acidic myo5 Δ acidic , YJC5441–3; 98, 80, and 84. las17 Δ acidic myo3 Δ acidic myo5 Δ acidic , YJC5205–7; 71, 79, and 99.
Lambda 10 3, supplied by Sutter Instrument Company, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lambda 10 3/product/Sutter Instrument Company
Average 93 stars, based on 1 article reviews
lambda 10 3 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
lambda 10–2 filter wheel  (Sutter Instrument Company)
90
Sutter Instrument Company lambda 10–2 filter wheel
(A–G) Null mutants lacking one or both type-I myosin. Cells express Sla2-GFP (A–D) or Abp1-GFP (E–G). (A) MSD plots for wild-type and myo5 Δ patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (B) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (C) Average time at the origin, from the appearance of a patch until it moved away or disappeared. (D) Phase II movement only. For each patch, data prior to movement were removed. (E) MSD plots for wild-type and mutant patches aligned at the start (left) or end (right) of their lifetimes. On the left, plots are truncated at the median lifetime or 16 s, whichever was less. (F) Percentage of patches that leave the origin, as in (B). (G) Average time at the origin, as in (C). (H–M) Mutants lacking Arp2/3-binding regions of one or both type-I myosins, termed myo3 Δ acidic and myo5 Δ acidic . The panels are similar to those above, with cells expressing Sla2-GFP (H–J) or Abp1-GFP (K–M). (H and K) MSD plots for wild-type or mutant patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (I and L) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (J and M) Average time at the origin, from the appearance of a patch until it moved away or disappeared. (N–S) Mutants lacking Arp2/3 binding regions of WASp/Las17 and type-I myosins. Cells express Sla2-GFP (N–P) or Abp1-GFP (Q–S). (N and Q) MSD plots for wild-type or mutant patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (O and P) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (R and S) Average time at the origin, from the appearance of a patch until it moved away or disappeared. Strain numbers and number of patches: (A–C) Wild-type, YJC4787–9; 94, 79, and 90. myo5 Δ, YJC4784–6; 103, 79, and 69. (D) Strains as in (A–C). Numbers of patches: wild-type – 88, 69, 85. myo5 Δ – 75, 40, 36. (E–G) Wild-type, YJC4815–7; 121, 110, and 130. myo3 Δ, YJC4409–11; 111, 115, and 105. myo5 Δ, YJC4813–4; 120 and 99. myo3 Δ myo5 Δ, YJC4770–2; 143, 141, and 126. (H–J) Wild-type, YJC5566–8; 71, 107, and 83. myo3 Δ acidic , YJC5563–5; 71, 75, and 101. myo5 Δ acidic , YJC5554–6; 86, 71, and 62. myo3 Δ acidic myo5 Δ acidic , YJC5557–9; 83, 65, and 83. (K–M) Wild-type, YJC4848 and 50; 116 and 87. myo3 Δ acidic , YJC4843–5; 119, 99, and 106. myo5 Δ acidic , YJC4840–2; 102, 111, and 99. myo3 Δ acidic myo5 Δ acidic , YJC4837–9; 96, 93, and 100. (N–P) Wild-type, YJC5566–8; 71, 107, and 83. las17 Δ acidic , YJC5551–3; 84, 64, and 69. las17 Δ acidic myo3 Δ acidic , YJC5560–2; 89, 71, and 68. las17 Δ acidic myo5 Δ acidic , YJC5548–50; 51, 66, and 57. las17 Δ acidic myo3 Δ acidic myo5 Δ acidic , YJC5545–7; 43, 53, and 54. (Q–S) las17 Δ acidic , YJC5208–10; 95, 76, and 89. las17 Δ acidic myo3 Δ acidic , YJC5438–40; 111, 104, and 109. las17 Δ acidic myo5 Δ acidic , YJC5441–3; 98, 80, and 84. las17 Δ acidic myo3 Δ acidic myo5 Δ acidic , YJC5205–7; 71, 79, and 99.
Lambda 10–2 Filter Wheel, supplied by Sutter Instrument Company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lambda 10–2 filter wheel/product/Sutter Instrument Company
Average 90 stars, based on 1 article reviews
lambda 10–2 filter wheel - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
lambda 10-2 emission filter wheel  (Sutter Instrument)
90
Sutter Instrument lambda 10-2 emission filter wheel
(A–G) Null mutants lacking one or both type-I myosin. Cells express Sla2-GFP (A–D) or Abp1-GFP (E–G). (A) MSD plots for wild-type and myo5 Δ patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (B) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (C) Average time at the origin, from the appearance of a patch until it moved away or disappeared. (D) Phase II movement only. For each patch, data prior to movement were removed. (E) MSD plots for wild-type and mutant patches aligned at the start (left) or end (right) of their lifetimes. On the left, plots are truncated at the median lifetime or 16 s, whichever was less. (F) Percentage of patches that leave the origin, as in (B). (G) Average time at the origin, as in (C). (H–M) Mutants lacking Arp2/3-binding regions of one or both type-I myosins, termed myo3 Δ acidic and myo5 Δ acidic . The panels are similar to those above, with cells expressing Sla2-GFP (H–J) or Abp1-GFP (K–M). (H and K) MSD plots for wild-type or mutant patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (I and L) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (J and M) Average time at the origin, from the appearance of a patch until it moved away or disappeared. (N–S) Mutants lacking Arp2/3 binding regions of WASp/Las17 and type-I myosins. Cells express Sla2-GFP (N–P) or Abp1-GFP (Q–S). (N and Q) MSD plots for wild-type or mutant patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (O and P) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (R and S) Average time at the origin, from the appearance of a patch until it moved away or disappeared. Strain numbers and number of patches: (A–C) Wild-type, YJC4787–9; 94, 79, and 90. myo5 Δ, YJC4784–6; 103, 79, and 69. (D) Strains as in (A–C). Numbers of patches: wild-type – 88, 69, 85. myo5 Δ – 75, 40, 36. (E–G) Wild-type, YJC4815–7; 121, 110, and 130. myo3 Δ, YJC4409–11; 111, 115, and 105. myo5 Δ, YJC4813–4; 120 and 99. myo3 Δ myo5 Δ, YJC4770–2; 143, 141, and 126. (H–J) Wild-type, YJC5566–8; 71, 107, and 83. myo3 Δ acidic , YJC5563–5; 71, 75, and 101. myo5 Δ acidic , YJC5554–6; 86, 71, and 62. myo3 Δ acidic myo5 Δ acidic , YJC5557–9; 83, 65, and 83. (K–M) Wild-type, YJC4848 and 50; 116 and 87. myo3 Δ acidic , YJC4843–5; 119, 99, and 106. myo5 Δ acidic , YJC4840–2; 102, 111, and 99. myo3 Δ acidic myo5 Δ acidic , YJC4837–9; 96, 93, and 100. (N–P) Wild-type, YJC5566–8; 71, 107, and 83. las17 Δ acidic , YJC5551–3; 84, 64, and 69. las17 Δ acidic myo3 Δ acidic , YJC5560–2; 89, 71, and 68. las17 Δ acidic myo5 Δ acidic , YJC5548–50; 51, 66, and 57. las17 Δ acidic myo3 Δ acidic myo5 Δ acidic , YJC5545–7; 43, 53, and 54. (Q–S) las17 Δ acidic , YJC5208–10; 95, 76, and 89. las17 Δ acidic myo3 Δ acidic , YJC5438–40; 111, 104, and 109. las17 Δ acidic myo5 Δ acidic , YJC5441–3; 98, 80, and 84. las17 Δ acidic myo3 Δ acidic myo5 Δ acidic , YJC5205–7; 71, 79, and 99.
Lambda 10 2 Emission Filter Wheel, supplied by Sutter Instrument, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lambda 10-2 emission filter wheel/product/Sutter Instrument
Average 90 stars, based on 1 article reviews
lambda 10-2 emission filter wheel - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
lambda 10 high-speed filter wheel  (Sutter Instrument Company)
90
Sutter Instrument Company lambda 10 high-speed filter wheel
(A–G) Null mutants lacking one or both type-I myosin. Cells express Sla2-GFP (A–D) or Abp1-GFP (E–G). (A) MSD plots for wild-type and myo5 Δ patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (B) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (C) Average time at the origin, from the appearance of a patch until it moved away or disappeared. (D) Phase II movement only. For each patch, data prior to movement were removed. (E) MSD plots for wild-type and mutant patches aligned at the start (left) or end (right) of their lifetimes. On the left, plots are truncated at the median lifetime or 16 s, whichever was less. (F) Percentage of patches that leave the origin, as in (B). (G) Average time at the origin, as in (C). (H–M) Mutants lacking Arp2/3-binding regions of one or both type-I myosins, termed myo3 Δ acidic and myo5 Δ acidic . The panels are similar to those above, with cells expressing Sla2-GFP (H–J) or Abp1-GFP (K–M). (H and K) MSD plots for wild-type or mutant patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (I and L) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (J and M) Average time at the origin, from the appearance of a patch until it moved away or disappeared. (N–S) Mutants lacking Arp2/3 binding regions of WASp/Las17 and type-I myosins. Cells express Sla2-GFP (N–P) or Abp1-GFP (Q–S). (N and Q) MSD plots for wild-type or mutant patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (O and P) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (R and S) Average time at the origin, from the appearance of a patch until it moved away or disappeared. Strain numbers and number of patches: (A–C) Wild-type, YJC4787–9; 94, 79, and 90. myo5 Δ, YJC4784–6; 103, 79, and 69. (D) Strains as in (A–C). Numbers of patches: wild-type – 88, 69, 85. myo5 Δ – 75, 40, 36. (E–G) Wild-type, YJC4815–7; 121, 110, and 130. myo3 Δ, YJC4409–11; 111, 115, and 105. myo5 Δ, YJC4813–4; 120 and 99. myo3 Δ myo5 Δ, YJC4770–2; 143, 141, and 126. (H–J) Wild-type, YJC5566–8; 71, 107, and 83. myo3 Δ acidic , YJC5563–5; 71, 75, and 101. myo5 Δ acidic , YJC5554–6; 86, 71, and 62. myo3 Δ acidic myo5 Δ acidic , YJC5557–9; 83, 65, and 83. (K–M) Wild-type, YJC4848 and 50; 116 and 87. myo3 Δ acidic , YJC4843–5; 119, 99, and 106. myo5 Δ acidic , YJC4840–2; 102, 111, and 99. myo3 Δ acidic myo5 Δ acidic , YJC4837–9; 96, 93, and 100. (N–P) Wild-type, YJC5566–8; 71, 107, and 83. las17 Δ acidic , YJC5551–3; 84, 64, and 69. las17 Δ acidic myo3 Δ acidic , YJC5560–2; 89, 71, and 68. las17 Δ acidic myo5 Δ acidic , YJC5548–50; 51, 66, and 57. las17 Δ acidic myo3 Δ acidic myo5 Δ acidic , YJC5545–7; 43, 53, and 54. (Q–S) las17 Δ acidic , YJC5208–10; 95, 76, and 89. las17 Δ acidic myo3 Δ acidic , YJC5438–40; 111, 104, and 109. las17 Δ acidic myo5 Δ acidic , YJC5441–3; 98, 80, and 84. las17 Δ acidic myo3 Δ acidic myo5 Δ acidic , YJC5205–7; 71, 79, and 99.
Lambda 10 High Speed Filter Wheel, supplied by Sutter Instrument Company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lambda 10 high-speed filter wheel/product/Sutter Instrument Company
Average 90 stars, based on 1 article reviews
lambda 10 high-speed filter wheel - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
sutter lambda 10-2 optical filter wheel controller  (Sutter Instrument Company)
90
Sutter Instrument Company sutter lambda 10-2 optical filter wheel controller
(A–G) Null mutants lacking one or both type-I myosin. Cells express Sla2-GFP (A–D) or Abp1-GFP (E–G). (A) MSD plots for wild-type and myo5 Δ patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (B) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (C) Average time at the origin, from the appearance of a patch until it moved away or disappeared. (D) Phase II movement only. For each patch, data prior to movement were removed. (E) MSD plots for wild-type and mutant patches aligned at the start (left) or end (right) of their lifetimes. On the left, plots are truncated at the median lifetime or 16 s, whichever was less. (F) Percentage of patches that leave the origin, as in (B). (G) Average time at the origin, as in (C). (H–M) Mutants lacking Arp2/3-binding regions of one or both type-I myosins, termed myo3 Δ acidic and myo5 Δ acidic . The panels are similar to those above, with cells expressing Sla2-GFP (H–J) or Abp1-GFP (K–M). (H and K) MSD plots for wild-type or mutant patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (I and L) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (J and M) Average time at the origin, from the appearance of a patch until it moved away or disappeared. (N–S) Mutants lacking Arp2/3 binding regions of WASp/Las17 and type-I myosins. Cells express Sla2-GFP (N–P) or Abp1-GFP (Q–S). (N and Q) MSD plots for wild-type or mutant patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (O and P) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (R and S) Average time at the origin, from the appearance of a patch until it moved away or disappeared. Strain numbers and number of patches: (A–C) Wild-type, YJC4787–9; 94, 79, and 90. myo5 Δ, YJC4784–6; 103, 79, and 69. (D) Strains as in (A–C). Numbers of patches: wild-type – 88, 69, 85. myo5 Δ – 75, 40, 36. (E–G) Wild-type, YJC4815–7; 121, 110, and 130. myo3 Δ, YJC4409–11; 111, 115, and 105. myo5 Δ, YJC4813–4; 120 and 99. myo3 Δ myo5 Δ, YJC4770–2; 143, 141, and 126. (H–J) Wild-type, YJC5566–8; 71, 107, and 83. myo3 Δ acidic , YJC5563–5; 71, 75, and 101. myo5 Δ acidic , YJC5554–6; 86, 71, and 62. myo3 Δ acidic myo5 Δ acidic , YJC5557–9; 83, 65, and 83. (K–M) Wild-type, YJC4848 and 50; 116 and 87. myo3 Δ acidic , YJC4843–5; 119, 99, and 106. myo5 Δ acidic , YJC4840–2; 102, 111, and 99. myo3 Δ acidic myo5 Δ acidic , YJC4837–9; 96, 93, and 100. (N–P) Wild-type, YJC5566–8; 71, 107, and 83. las17 Δ acidic , YJC5551–3; 84, 64, and 69. las17 Δ acidic myo3 Δ acidic , YJC5560–2; 89, 71, and 68. las17 Δ acidic myo5 Δ acidic , YJC5548–50; 51, 66, and 57. las17 Δ acidic myo3 Δ acidic myo5 Δ acidic , YJC5545–7; 43, 53, and 54. (Q–S) las17 Δ acidic , YJC5208–10; 95, 76, and 89. las17 Δ acidic myo3 Δ acidic , YJC5438–40; 111, 104, and 109. las17 Δ acidic myo5 Δ acidic , YJC5441–3; 98, 80, and 84. las17 Δ acidic myo3 Δ acidic myo5 Δ acidic , YJC5205–7; 71, 79, and 99.
Sutter Lambda 10 2 Optical Filter Wheel Controller, supplied by Sutter Instrument Company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sutter lambda 10-2 optical filter wheel controller/product/Sutter Instrument Company
Average 90 stars, based on 1 article reviews
sutter lambda 10-2 optical filter wheel controller - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
lambda-10-filtered wheel driver  (Sutter Instrument Company)
90
Sutter Instrument Company lambda-10-filtered wheel driver
(A–G) Null mutants lacking one or both type-I myosin. Cells express Sla2-GFP (A–D) or Abp1-GFP (E–G). (A) MSD plots for wild-type and myo5 Δ patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (B) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (C) Average time at the origin, from the appearance of a patch until it moved away or disappeared. (D) Phase II movement only. For each patch, data prior to movement were removed. (E) MSD plots for wild-type and mutant patches aligned at the start (left) or end (right) of their lifetimes. On the left, plots are truncated at the median lifetime or 16 s, whichever was less. (F) Percentage of patches that leave the origin, as in (B). (G) Average time at the origin, as in (C). (H–M) Mutants lacking Arp2/3-binding regions of one or both type-I myosins, termed myo3 Δ acidic and myo5 Δ acidic . The panels are similar to those above, with cells expressing Sla2-GFP (H–J) or Abp1-GFP (K–M). (H and K) MSD plots for wild-type or mutant patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (I and L) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (J and M) Average time at the origin, from the appearance of a patch until it moved away or disappeared. (N–S) Mutants lacking Arp2/3 binding regions of WASp/Las17 and type-I myosins. Cells express Sla2-GFP (N–P) or Abp1-GFP (Q–S). (N and Q) MSD plots for wild-type or mutant patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (O and P) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (R and S) Average time at the origin, from the appearance of a patch until it moved away or disappeared. Strain numbers and number of patches: (A–C) Wild-type, YJC4787–9; 94, 79, and 90. myo5 Δ, YJC4784–6; 103, 79, and 69. (D) Strains as in (A–C). Numbers of patches: wild-type – 88, 69, 85. myo5 Δ – 75, 40, 36. (E–G) Wild-type, YJC4815–7; 121, 110, and 130. myo3 Δ, YJC4409–11; 111, 115, and 105. myo5 Δ, YJC4813–4; 120 and 99. myo3 Δ myo5 Δ, YJC4770–2; 143, 141, and 126. (H–J) Wild-type, YJC5566–8; 71, 107, and 83. myo3 Δ acidic , YJC5563–5; 71, 75, and 101. myo5 Δ acidic , YJC5554–6; 86, 71, and 62. myo3 Δ acidic myo5 Δ acidic , YJC5557–9; 83, 65, and 83. (K–M) Wild-type, YJC4848 and 50; 116 and 87. myo3 Δ acidic , YJC4843–5; 119, 99, and 106. myo5 Δ acidic , YJC4840–2; 102, 111, and 99. myo3 Δ acidic myo5 Δ acidic , YJC4837–9; 96, 93, and 100. (N–P) Wild-type, YJC5566–8; 71, 107, and 83. las17 Δ acidic , YJC5551–3; 84, 64, and 69. las17 Δ acidic myo3 Δ acidic , YJC5560–2; 89, 71, and 68. las17 Δ acidic myo5 Δ acidic , YJC5548–50; 51, 66, and 57. las17 Δ acidic myo3 Δ acidic myo5 Δ acidic , YJC5545–7; 43, 53, and 54. (Q–S) las17 Δ acidic , YJC5208–10; 95, 76, and 89. las17 Δ acidic myo3 Δ acidic , YJC5438–40; 111, 104, and 109. las17 Δ acidic myo5 Δ acidic , YJC5441–3; 98, 80, and 84. las17 Δ acidic myo3 Δ acidic myo5 Δ acidic , YJC5205–7; 71, 79, and 99.
Lambda 10 Filtered Wheel Driver, supplied by Sutter Instrument Company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lambda-10-filtered wheel driver/product/Sutter Instrument Company
Average 90 stars, based on 1 article reviews
lambda-10-filtered wheel driver - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
xenon light source and filter wheel lambda ls and lambda-10  (Sutter Instrument Company)
90
Sutter Instrument Company xenon light source and filter wheel lambda ls and lambda-10
(A–G) Null mutants lacking one or both type-I myosin. Cells express Sla2-GFP (A–D) or Abp1-GFP (E–G). (A) MSD plots for wild-type and myo5 Δ patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (B) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (C) Average time at the origin, from the appearance of a patch until it moved away or disappeared. (D) Phase II movement only. For each patch, data prior to movement were removed. (E) MSD plots for wild-type and mutant patches aligned at the start (left) or end (right) of their lifetimes. On the left, plots are truncated at the median lifetime or 16 s, whichever was less. (F) Percentage of patches that leave the origin, as in (B). (G) Average time at the origin, as in (C). (H–M) Mutants lacking Arp2/3-binding regions of one or both type-I myosins, termed myo3 Δ acidic and myo5 Δ acidic . The panels are similar to those above, with cells expressing Sla2-GFP (H–J) or Abp1-GFP (K–M). (H and K) MSD plots for wild-type or mutant patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (I and L) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (J and M) Average time at the origin, from the appearance of a patch until it moved away or disappeared. (N–S) Mutants lacking Arp2/3 binding regions of WASp/Las17 and type-I myosins. Cells express Sla2-GFP (N–P) or Abp1-GFP (Q–S). (N and Q) MSD plots for wild-type or mutant patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (O and P) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (R and S) Average time at the origin, from the appearance of a patch until it moved away or disappeared. Strain numbers and number of patches: (A–C) Wild-type, YJC4787–9; 94, 79, and 90. myo5 Δ, YJC4784–6; 103, 79, and 69. (D) Strains as in (A–C). Numbers of patches: wild-type – 88, 69, 85. myo5 Δ – 75, 40, 36. (E–G) Wild-type, YJC4815–7; 121, 110, and 130. myo3 Δ, YJC4409–11; 111, 115, and 105. myo5 Δ, YJC4813–4; 120 and 99. myo3 Δ myo5 Δ, YJC4770–2; 143, 141, and 126. (H–J) Wild-type, YJC5566–8; 71, 107, and 83. myo3 Δ acidic , YJC5563–5; 71, 75, and 101. myo5 Δ acidic , YJC5554–6; 86, 71, and 62. myo3 Δ acidic myo5 Δ acidic , YJC5557–9; 83, 65, and 83. (K–M) Wild-type, YJC4848 and 50; 116 and 87. myo3 Δ acidic , YJC4843–5; 119, 99, and 106. myo5 Δ acidic , YJC4840–2; 102, 111, and 99. myo3 Δ acidic myo5 Δ acidic , YJC4837–9; 96, 93, and 100. (N–P) Wild-type, YJC5566–8; 71, 107, and 83. las17 Δ acidic , YJC5551–3; 84, 64, and 69. las17 Δ acidic myo3 Δ acidic , YJC5560–2; 89, 71, and 68. las17 Δ acidic myo5 Δ acidic , YJC5548–50; 51, 66, and 57. las17 Δ acidic myo3 Δ acidic myo5 Δ acidic , YJC5545–7; 43, 53, and 54. (Q–S) las17 Δ acidic , YJC5208–10; 95, 76, and 89. las17 Δ acidic myo3 Δ acidic , YJC5438–40; 111, 104, and 109. las17 Δ acidic myo5 Δ acidic , YJC5441–3; 98, 80, and 84. las17 Δ acidic myo3 Δ acidic myo5 Δ acidic , YJC5205–7; 71, 79, and 99.
Xenon Light Source And Filter Wheel Lambda Ls And Lambda 10, supplied by Sutter Instrument Company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/xenon light source and filter wheel lambda ls and lambda-10/product/Sutter Instrument Company
Average 90 stars, based on 1 article reviews
xenon light source and filter wheel lambda ls and lambda-10 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
filter wheel sutter instruments lambda 10b  (Sutter Instrument Company)
90
Sutter Instrument Company filter wheel sutter instruments lambda 10b

Filter Wheel Sutter Instruments Lambda 10b, supplied by Sutter Instrument Company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/filter wheel sutter instruments lambda 10b/product/Sutter Instrument Company
Average 90 stars, based on 1 article reviews
filter wheel sutter instruments lambda 10b - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
lambda 10-2 filter wheel controller  (Chroma Technology Corporation)
90
Chroma Technology Corporation lambda 10-2 filter wheel controller

Lambda 10 2 Filter Wheel Controller, supplied by Chroma Technology Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lambda 10-2 filter wheel controller/product/Chroma Technology Corporation
Average 90 stars, based on 1 article reviews
lambda 10-2 filter wheel controller - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
lambda 10–2 filter wheel controller  (Hamamatsu)
90
Hamamatsu lambda 10–2 filter wheel controller

Lambda 10–2 Filter Wheel Controller, supplied by Hamamatsu, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lambda 10–2 filter wheel controller/product/Hamamatsu
Average 90 stars, based on 1 article reviews
lambda 10–2 filter wheel controller - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


(A–G) Null mutants lacking one or both type-I myosin. Cells express Sla2-GFP (A–D) or Abp1-GFP (E–G). (A) MSD plots for wild-type and myo5 Δ patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (B) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (C) Average time at the origin, from the appearance of a patch until it moved away or disappeared. (D) Phase II movement only. For each patch, data prior to movement were removed. (E) MSD plots for wild-type and mutant patches aligned at the start (left) or end (right) of their lifetimes. On the left, plots are truncated at the median lifetime or 16 s, whichever was less. (F) Percentage of patches that leave the origin, as in (B). (G) Average time at the origin, as in (C). (H–M) Mutants lacking Arp2/3-binding regions of one or both type-I myosins, termed myo3 Δ acidic and myo5 Δ acidic . The panels are similar to those above, with cells expressing Sla2-GFP (H–J) or Abp1-GFP (K–M). (H and K) MSD plots for wild-type or mutant patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (I and L) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (J and M) Average time at the origin, from the appearance of a patch until it moved away or disappeared. (N–S) Mutants lacking Arp2/3 binding regions of WASp/Las17 and type-I myosins. Cells express Sla2-GFP (N–P) or Abp1-GFP (Q–S). (N and Q) MSD plots for wild-type or mutant patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (O and P) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (R and S) Average time at the origin, from the appearance of a patch until it moved away or disappeared. Strain numbers and number of patches: (A–C) Wild-type, YJC4787–9; 94, 79, and 90. myo5 Δ, YJC4784–6; 103, 79, and 69. (D) Strains as in (A–C). Numbers of patches: wild-type – 88, 69, 85. myo5 Δ – 75, 40, 36. (E–G) Wild-type, YJC4815–7; 121, 110, and 130. myo3 Δ, YJC4409–11; 111, 115, and 105. myo5 Δ, YJC4813–4; 120 and 99. myo3 Δ myo5 Δ, YJC4770–2; 143, 141, and 126. (H–J) Wild-type, YJC5566–8; 71, 107, and 83. myo3 Δ acidic , YJC5563–5; 71, 75, and 101. myo5 Δ acidic , YJC5554–6; 86, 71, and 62. myo3 Δ acidic myo5 Δ acidic , YJC5557–9; 83, 65, and 83. (K–M) Wild-type, YJC4848 and 50; 116 and 87. myo3 Δ acidic , YJC4843–5; 119, 99, and 106. myo5 Δ acidic , YJC4840–2; 102, 111, and 99. myo3 Δ acidic myo5 Δ acidic , YJC4837–9; 96, 93, and 100. (N–P) Wild-type, YJC5566–8; 71, 107, and 83. las17 Δ acidic , YJC5551–3; 84, 64, and 69. las17 Δ acidic myo3 Δ acidic , YJC5560–2; 89, 71, and 68. las17 Δ acidic myo5 Δ acidic , YJC5548–50; 51, 66, and 57. las17 Δ acidic myo3 Δ acidic myo5 Δ acidic , YJC5545–7; 43, 53, and 54. (Q–S) las17 Δ acidic , YJC5208–10; 95, 76, and 89. las17 Δ acidic myo3 Δ acidic , YJC5438–40; 111, 104, and 109. las17 Δ acidic myo5 Δ acidic , YJC5441–3; 98, 80, and 84. las17 Δ acidic myo3 Δ acidic myo5 Δ acidic , YJC5205–7; 71, 79, and 99.

Journal: PLoS Biology

Article Title: Distinct Roles for Arp2/3 Regulators in Actin Assembly and Endocytosis

doi: 10.1371/journal.pbio.0060001

Figure Lengend Snippet: (A–G) Null mutants lacking one or both type-I myosin. Cells express Sla2-GFP (A–D) or Abp1-GFP (E–G). (A) MSD plots for wild-type and myo5 Δ patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (B) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (C) Average time at the origin, from the appearance of a patch until it moved away or disappeared. (D) Phase II movement only. For each patch, data prior to movement were removed. (E) MSD plots for wild-type and mutant patches aligned at the start (left) or end (right) of their lifetimes. On the left, plots are truncated at the median lifetime or 16 s, whichever was less. (F) Percentage of patches that leave the origin, as in (B). (G) Average time at the origin, as in (C). (H–M) Mutants lacking Arp2/3-binding regions of one or both type-I myosins, termed myo3 Δ acidic and myo5 Δ acidic . The panels are similar to those above, with cells expressing Sla2-GFP (H–J) or Abp1-GFP (K–M). (H and K) MSD plots for wild-type or mutant patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (I and L) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (J and M) Average time at the origin, from the appearance of a patch until it moved away or disappeared. (N–S) Mutants lacking Arp2/3 binding regions of WASp/Las17 and type-I myosins. Cells express Sla2-GFP (N–P) or Abp1-GFP (Q–S). (N and Q) MSD plots for wild-type or mutant patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (O and P) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (R and S) Average time at the origin, from the appearance of a patch until it moved away or disappeared. Strain numbers and number of patches: (A–C) Wild-type, YJC4787–9; 94, 79, and 90. myo5 Δ, YJC4784–6; 103, 79, and 69. (D) Strains as in (A–C). Numbers of patches: wild-type – 88, 69, 85. myo5 Δ – 75, 40, 36. (E–G) Wild-type, YJC4815–7; 121, 110, and 130. myo3 Δ, YJC4409–11; 111, 115, and 105. myo5 Δ, YJC4813–4; 120 and 99. myo3 Δ myo5 Δ, YJC4770–2; 143, 141, and 126. (H–J) Wild-type, YJC5566–8; 71, 107, and 83. myo3 Δ acidic , YJC5563–5; 71, 75, and 101. myo5 Δ acidic , YJC5554–6; 86, 71, and 62. myo3 Δ acidic myo5 Δ acidic , YJC5557–9; 83, 65, and 83. (K–M) Wild-type, YJC4848 and 50; 116 and 87. myo3 Δ acidic , YJC4843–5; 119, 99, and 106. myo5 Δ acidic , YJC4840–2; 102, 111, and 99. myo3 Δ acidic myo5 Δ acidic , YJC4837–9; 96, 93, and 100. (N–P) Wild-type, YJC5566–8; 71, 107, and 83. las17 Δ acidic , YJC5551–3; 84, 64, and 69. las17 Δ acidic myo3 Δ acidic , YJC5560–2; 89, 71, and 68. las17 Δ acidic myo5 Δ acidic , YJC5548–50; 51, 66, and 57. las17 Δ acidic myo3 Δ acidic myo5 Δ acidic , YJC5545–7; 43, 53, and 54. (Q–S) las17 Δ acidic , YJC5208–10; 95, 76, and 89. las17 Δ acidic myo3 Δ acidic , YJC5438–40; 111, 104, and 109. las17 Δ acidic myo5 Δ acidic , YJC5441–3; 98, 80, and 84. las17 Δ acidic myo3 Δ acidic myo5 Δ acidic , YJC5205–7; 71, 79, and 99.

Article Snippet: Two color images were collected sequentially using a LMM5 Laser Merge Module (Spectral Applied Research), a multipass dichroic mirror, and emission filters in a Lambda 10–3 high-speed filter wheel (Sutter Instruments).

Techniques: Mutagenesis, Binding Assay, Expressing

Cells express Sla2-GFP (A–C) or Abp1-GFP (D–F). ( A and D) MSD plots for wild-type and mutant patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (B and E) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (C and F) Average time at the origin, from the appearance of a patch until it moved away or disappeared. Strain numbers and numbers of patches: (A–C) Wild-type, YJC5707 - 9; 66, 84, and 69. las17 Δ acidic , YJC5713–5; 100, 95, and 104. pan1 Δ acidic , YJC5710–2; 103, 76, and 74. las17 Δ acidic pan1 Δ acidic , YJC5716–8; 100, 86, and 91. (D–F) Wild-type, YJC5719–22; 99, 100, 114, and 98. las17 Δ acidic , YJC5726, 8 & 9; 95, 88, and 84. pan1 Δ acidic , YJC5723–5; 102, 94, and 139. las17 Δ acidic pan1 Δ acidic , YJC5730–3; 77, 70, 50, and 50. Error bars are ± standard error.

Journal: PLoS Biology

Article Title: Distinct Roles for Arp2/3 Regulators in Actin Assembly and Endocytosis

doi: 10.1371/journal.pbio.0060001

Figure Lengend Snippet: Cells express Sla2-GFP (A–C) or Abp1-GFP (D–F). ( A and D) MSD plots for wild-type and mutant patches aligned at the start (left) or end (right) of their lifetimes. The curves on the left are truncated at the median lifetime. (B and E) Percentage of patches that leave the origin. Mean of values for three segregants is shown. (C and F) Average time at the origin, from the appearance of a patch until it moved away or disappeared. Strain numbers and numbers of patches: (A–C) Wild-type, YJC5707 - 9; 66, 84, and 69. las17 Δ acidic , YJC5713–5; 100, 95, and 104. pan1 Δ acidic , YJC5710–2; 103, 76, and 74. las17 Δ acidic pan1 Δ acidic , YJC5716–8; 100, 86, and 91. (D–F) Wild-type, YJC5719–22; 99, 100, 114, and 98. las17 Δ acidic , YJC5726, 8 & 9; 95, 88, and 84. pan1 Δ acidic , YJC5723–5; 102, 94, and 139. las17 Δ acidic pan1 Δ acidic , YJC5730–3; 77, 70, 50, and 50. Error bars are ± standard error.

Article Snippet: Two color images were collected sequentially using a LMM5 Laser Merge Module (Spectral Applied Research), a multipass dichroic mirror, and emission filters in a Lambda 10–3 high-speed filter wheel (Sutter Instruments).

Techniques: Mutagenesis

Journal: eLife

Article Title: Lactate is an energy substrate for rodent cortical neurons and enhances their firing activity

doi: 10.7554/eLife.71424

Figure Lengend Snippet:

Article Snippet: Other , Filter wheel , Sutter Instruments , Lambda 10B , .

Techniques: Recombinant, Plasmid Preparation, Sequencing, Reverse Transcription, Software, Microscopy